drugset
drugset / Trial / NCT05862428

Rectal Misoprostol in Women Undergoing Total Abdominal Hysterectomy for Intraoperative Blood Loss Reduction

NCT05862428 ↗

Completed 56 enrolled Queen Savang Vadhana Memorial Hospital, Thailand
RandomizedParallel-groupOpen-labelPrevention

Summary

Comparing of the intraoperative blood loss between group rectal misoprostol group and control group

Timeline

Start
2022-02-18
Primary completion
2022-09-26
Completion
2022-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Rectal

Indications

No indication recorded.